Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sushi domain containing 2 pseudogene 2 (SUSD2P2) is classified as a pseudogene, not a protein-coding gene or functional receptor/enzyme. It is related to the sushi domain containing 2 gene (SUSD2), which encodes a cell surface protein with roles in cell adhesion and cancer biology, but SUSD2P2 itself does not encode a functional protein and lacks known biological or therapeutic function. As a pseudogene, it is not considered a therapeutic target, does not interact with drugs, and plays no established biological or disease-modifying roles. Key context: - SUSD2P2 is a pseudogene entry and does not code for an active protein or therapeutic target. - The functional gene in this family, SUSD2, has roles in cancer progression and cell adhesion, but those findings do not apply to SUSD2P2. - No evidence supports SUSD2P2 being targeted by drugs, acting as a biomarker, or having safety concerns. SUSD2P2 should not be listed as a molecular target or receptor in structured therapeutic databases and its inclusion as an active target is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sushi domain containing 2 pseudogene 2 (SUSD2P2).